Summary
The interaction between BW755C (3-amino-1-[m-(trifluoromethyl)phenyl]-2-pyrazoline), a potent inhibitor of both lipoxygenase and cyclo-oxygenase, and respiratory chain in mitochondria and electron transport particles (ETP) from rat livers was examined. BW755C accelerated the oxygen uptake by mitochondria without the addition of substrate for the respiratory chain. Spectrophotometric study revealed that BW755C was quickly oxidized by cytochrome oxidase in mitochondria to a compound possessing an absorption maximum at 524 nm. p-Phenylenediamine (p-diaminobenzene, PPDA), which, like BW755C, serves as an electron donor to cytoschrome oxidase, was shown to inhibit the generation of active oxygen in macrophages; the inhibition was stronger than that of BW755C. These results strongly suggest that the oxidative conversion of BW755C by mitochondrial cytochrome oxidase is associated with its potentially inhibitory action on the active oxygen-generating system in phagocytes.
This is a preview of subscription content, log in via an institution to check access.
Abbreviations
- PPDA:
-
p-phenylenediamine
- NSAIDS:
-
non-steroidal anti-inflammatory drugs
- MEM:
-
minimum essential medium
References
Ferreira, S.H., and Vane, J.R., in: The Prostaglandins 2, p. 1. Ed. P.W. Ramwell, Plenum Press, New York 1974.
Moncada, S., and Vane, J.R., in: Advances in Internal Medicine, p. 1. Ed. G.H. Stollerman. Year Book Medical Publishers, Chicago 1979.
Higgs, G.A., Flower, R.J., and Vane, J.R., Biochem. Pharmac.28 (1979) 1959.
Orii, Y., and Okunuki, K., J. Biochem.53 (1963) 489.
Segal, A.W., and Jones, O.T.G., Biochem. biophys. Res. Commun.88 (1979) 130.
Gabig, T.G., Schervish, E.W., and Santinga, J.T., J. biol. Chem.257 (1982) 4114.
Gabig, T.G., and Lefker, B.A., Biochem. biophys. Res. Commun.118 (1984) 430.
Schneider, W.C., J. biol. Chem.176 (1948) 259.
Ruzicka, F.J., and Crane, F.L., Biochim. biophys. Acta223 (1970) 71.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J., J. biol. Chem.193 (1951) 265.
Mibu, H., Hasegawa, J., Niwa, M., Nozaki, M., Tsurumi, K., and Fujimura, H., Folia pharmac. Japan83 (1984) 355.
Chance, B., and Williams, G.R., J. biol. Chem.227 (1955) 383.
Brody, T.M., Pharmac. Rev.7 (1955) 335.
Terada, H., Biochim. biophys. Acta639 (1981) 225.
Heytler, P.G., in: Inhibitors of Mitochondrial Function, p. 199. Eds M. Erecinska and D.F. Wilson. Pergamon Press, Oxford/New York 1981.
Shiojiri, H., Kawai, K., Nozawa, Y., Nozaki, M., Tsurumi, K., and Fujimura, H., Presentation at Ist World Conference on Inflammation (Italy) 1984.
Orii, Y., and Okunuki, K., J. Biochem.53 (1963) 489.
Orii, Y., and Okunuki, K., J. Biochem.57 (1965) 45.
Author information
Authors and Affiliations
Additional information
The authors are indebted to Dr M. Hori, Gifu College of Pharmacy and to Dr Y. Orii, Kyoto University for their kind supplies of BW755C and pure cytochrome oxidase, respectively.
Rights and permissions
About this article
Cite this article
Kawai, K., Hasegawa, J., Shiojiri, H. et al. Interaction of BW755C, a potent inhibitor of lipoxygenase and cyclo-oxygenase, with mitochondrial cytochrome oxidase. Experientia 41, 490–492 (1985). https://doi.org/10.1007/BF01966164
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01966164